Speakers 2025

Keynote Speech – Phage Therapy 2030: Getting from here to there

Robert T. Schooley

University of California, San Diego, USA

Bacteriophage Therapy: A Renaissance – From Military Medicine to Civilian Healthcare

Christian Willy

Military Academic Hospital Bundeswehr Berlin, Germany

Complex Phage Communities Control Gut (im)balances and May Hold the Key to Restore Gut Biosis

Dennis Sandris Nielsen

University of Copenhagen, Denmark

Inhaled Bacteriophage Therapy for Multidrug Resistant Pseudomonas Aeruginosa: Advances & Perspectives

Gail L. Stanley

Yale University, USA

KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut

Franklin Nobrega

University of Southampton, United Kingdom

Optimizing the Phage-Bacteria Ratio in Phage Therapy: Metagenomic Insights into Microbial Balance and Dysbiosis

Domenico Frezza

University of Roma Tor Vergata, Italy

Phage Defense Systems: Are they an Obstacle for Phage Therapy?

Stan J.J. Brouns

Delft University of Technology, The Netherlands

Biocontrol of Phage Resistance in Pseudomonas Infections – Fitness Trade-Offs Between Phages and Antibiotic Sensitivity

Jumpei Fujiki

Rakuno Gakuen University, Japan

Yersinia Phage Stories: Impact on Phage Therapy

Mikael Skurnik

University of Helsinki, Finland

Targeting Tumors with Engineered Phages: A New Frontier in Precision Oncology

Alberto Danielli

University of Bologna, Italy

Endolysin B as a New Approach & Archetype in M. Tuberculosis Treatment

Loris Rizzello

University of Milan, Italy

Ex vivo pig lung as a new Cystic Fibrosis model for the study of Pseudomonas aeruginosa biofilm infection and phage therapy application

Marco Cafora

University of Milan, Italy

Translating Phage Therapy into the Clinic: Recent Accomplishments and Next Challenges

Jeremy Barr

Monash University, Australia

Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery

Christian Kühn

Hannover Medical School, Germany

Phage Therapy in Veterinary Medicine: Presentation of First Clinical Trial in Japan

Hidetomo Iwano

Rakuno Gakuen University, Japan

Bacteriophages Applications in Broiler Farms: Strategies & Perspectives

Sandra Sevilla-Navarro

Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana, Spain

Phage Therapy in Europe: Legal, Regulatory and Ethic Issues

Barbara Brenner

Kanzlei BRENNER, Germany

CellMaker- The Ideal Solution for Scalable Phage Manufacturing

Ruta Teterovska

Cellexus International Ltd, United Kingdom

Good Manufacturing Practices For Phage Production : Scaling Production, Quality Control & Standardization, Market Access & Commercialization Strategies

Frenk Smrekar

JAFRAL

Engineering Phages for Cancer Therapy: Insights into Immune Interactions and Targeting in Ex-Vivo and In-Vivo Models

Alena Kaltenbrunner

University of Bologna, Italy